AM
AMRX
Market ClosedAmneal Pharmaceuticals, Inc.
US
8.50K employees
CEO: Chirag K. Patel
Founded: 2018
$17.92
+$0.00(+NaN%)
Market Cap
5.72B
Beta
1.26
52W Range
N/A
Dividend Yield
0.00%
AMRX Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for AMRX built from valuation, fundamentals, sentiment, and risk models
Investment Signal
HoldPass %
57.14%
Score
4/7
Fair Value Estimate
Cash flow analysis • Multiple methods
$15.03
AI Price Target
Machine learning • Price prediction
$22.53
Market Sentiment
News & social media analysis
0.00
Value Investor Price
Classic value analysis
$0.00
Financial Health
Bankruptcy risk assessment
2.24
Quality Score
Financial strength rating
7.00
AI Investment Grade
Deep analysis of filings & news
65.00
Key Investment Highlights
Important factors affecting AMRX investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
55.56% Good
Conditions Met
20.00/36.00
Due Diligence Score
55.56%Due Diligence Conditions
Investment analysis conditions and results
Fail | |
Fail | |
Pass | |
Fail | |
Pass | |
Fail |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for AMRX
No recent news available for AMRX
Core Financials
Loading financial data for AMRX...
Explore AMRX
AMRX in the Healthcare
Mid Cap